Results for tag: "Delstrigo"

Delstrigo is a combination antiretroviral drug used to treat HIV/AIDS. It is a fixed-dose combination of three drugs: doravirine, lamivudine, and tenofovir disoproxil fumarate. Delstrigo is used to treat HIV-1 infection in adults and adolescents aged 12 years and older. It is not recommended for use in children under 12 years of age. Delstrigo works by blocking the action of HIV-1 reverse transcriptase, an enzyme that is essential for the virus to replicate. This helps to reduce the amount of HIV-1 in the body and prevent further damage to the immune system. Delstrigo is available in the market as a tablet and is taken once daily with food. It is important to take Delstrigo exactly as prescribed by the doctor. Delstrigo should not be used in combination with other antiretroviral drugs. Companies in the Delstrigo market include Merck & Co., Inc., Gilead Sciences, Inc., Bristol-Myers Squibb Company, and ViiV Healthcare. Show Less Read more